0001104659-21-019903.txt : 20210210
0001104659-21-019903.hdr.sgml : 20210210
20210210170040
ACCESSION NUMBER: 0001104659-21-019903
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210208
FILED AS OF DATE: 20210210
DATE AS OF CHANGE: 20210210
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Murphy-Chutorian Douglas
CENTRAL INDEX KEY: 0001594342
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36305
FILM NUMBER: 21614881
MAIL ADDRESS:
STREET 1: C/O SEMLER SCIENTIFIC, INC.
STREET 2: 911 BERN COURT, SUITE 110
CITY: SAN JOSE
STATE: CA
ZIP: 95112
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Semler Scientific, Inc.
CENTRAL INDEX KEY: 0001554859
STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
IRS NUMBER: 261367393
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2340-2348 WALSH AVENUE, SUITE 2344
CITY: SANTA CLARA
STATE: CA
ZIP: 95051
BUSINESS PHONE: 408-627-4557
MAIL ADDRESS:
STREET 1: 2340-2348 WALSH AVENUE, SUITE 2344
CITY: SANTA CLARA
STATE: CA
ZIP: 95051
4
1
tm216117-1_4seq1.xml
OWNERSHIP DOCUMENT
X0306
4
2021-02-08
0
0001554859
Semler Scientific, Inc.
SMLR
0001594342
Murphy-Chutorian Douglas
C/O SEMLER SCIENTIFIC, INC.
2340-2348 WALSH AVENUE, SUITE 2344
SANTA CLARA
CA
95051
1
1
1
0
Chief Executive Officer
Common Stock
2021-02-08
4
M
0
1250
0.52
A
1250
D
Common Stock
2021-02-08
4
S
0
50
98.00
D
1200
D
Common Stock
2021-02-08
4
S
0
300
99.367
D
900
D
Common Stock
2021-02-08
4
S
0
250
100.084
D
650
D
Common Stock
2021-02-08
4
S
0
295
101.3525
D
355
D
Common Stock
2021-02-08
4
S
0
55
102.9182
D
300
D
Common Stock
2021-02-08
4
S
0
300
103.0483
D
0
D
Common Stock
53571
I
By Trust
Common Stock Option (Right to Buy)
0.52
2021-02-08
4
M
0
1250
0.00
D
2022-11-21
Common Stock
1250
16250
D
Shares sold pursuant to a 10b5-1 trading plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $99.00 to $99.55, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 2 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.00 to $100.12, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 3 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.00 to $101.99, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 4 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $102.10 to $103.00, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 5 to this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $103.01 to $103.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote 6 to this Form 4.
Shares are held by the Murphy-Chutorian Family Trust U/D/T dated January 13, 1997, of which the Reporting Person is co-Trustee with his spouse.
Fully vested and exercisable.
/s/ Dan Conger, attorney-in-fact
2021-02-10